United States Facial Injectables Market Report 2017

Publisher Name :
Date: 10-Nov-2017
No. of pages: 113
Inquire Before Buying

In this report, the United States Facial Injectables market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

- The West

- Southwest

- The Middle Atlantic

- New England

- The South

- The Midwest

with sales (volume), revenue (value), market share and growth rate of Facial Injectables in these regions, from 2012 to 2022 (forecast).

United States Facial Injectables market competition by top manufacturers/players, with Facial Injectables sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

- Allergan

- Prollenium Medical Technologies Inc

- Galderma

- Merz Aesthetics

- Ipsen Group

- Bloomage BioTechnology

- Hangzhou Techderm Biological Products

- Laboratory Obvieline

- Medytox

- Polymekon

- Qufu Guanglong Biochem

- Revitacare

- Suneva Medical

- SciVision Biotech

- Speciality European Pharma

- Syneron

- Visionmed

- AQTIS Medical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Botulinum Toxin

- Hyaluronic Acid

- Collagen

- Particle & Polymer Fillers (PPF)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Hospitals

- Ambulatory Surgical Centers

- Cosmetic Centers

- Dermatology Clinics

- Physician Clinics

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Facial Injectables Market Report 2017

Table of Contents
United States Facial Injectables Market Report 2017
1 Facial Injectables Overview
1.1 Product Overview and Scope of Facial Injectables
1.2 Classification of Facial Injectables by Product Category
1.2.1 United States Facial Injectables Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Facial Injectables Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Botulinum Toxin
1.2.4 Hyaluronic Acid
1.2.5 Collagen
1.2.6 Particle & Polymer Fillers (PPF)
1.3 United States Facial Injectables Market by Application/End Users
1.3.1 United States Facial Injectables Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Cosmetic Centers
1.3.5 Dermatology Clinics
1.3.6 Physician Clinics
1.4 United States Facial Injectables Market by Region
1.4.1 United States Facial Injectables Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Facial Injectables Status and Prospect (2012-2022)
1.4.3 Southwest Facial Injectables Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Facial Injectables Status and Prospect (2012-2022)
1.4.5 New England Facial Injectables Status and Prospect (2012-2022)
1.4.6 The South Facial Injectables Status and Prospect (2012-2022)
1.4.7 The Midwest Facial Injectables Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Facial Injectables (2012-2022)
1.5.1 United States Facial Injectables Sales and Growth Rate (2012-2022)
1.5.2 United States Facial Injectables Revenue and Growth Rate (2012-2022)
2 United States Facial Injectables Market Competition by Players/Suppliers
2.1 United States Facial Injectables Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Facial Injectables Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Facial Injectables Average Price by Players/Suppliers (2012-2017)
2.4 United States Facial Injectables Market Competitive Situation and Trends
2.4.1 United States Facial Injectables Market Concentration Rate
2.4.2 United States Facial Injectables Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Facial Injectables Manufacturing Base Distribution, Sales Area, Product Type
3 United States Facial Injectables Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Facial Injectables Sales and Market Share by Region (2012-2017)
3.2 United States Facial Injectables Revenue and Market Share by Region (2012-2017)
3.3 United States Facial Injectables Price by Region (2012-2017)
4 United States Facial Injectables Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Facial Injectables Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Facial Injectables Revenue and Market Share by Type (2012-2017)
4.3 United States Facial Injectables Price by Type (2012-2017)
4.4 United States Facial Injectables Sales Growth Rate by Type (2012-2017)
5 United States Facial Injectables Sales (Volume) by Application (2012-2017)
5.1 United States Facial Injectables Sales and Market Share by Application (2012-2017)
5.2 United States Facial Injectables Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Facial Injectables Players/Suppliers Profiles and Sales Data
6.1 Allergan
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Facial Injectables Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Allergan Facial Injectables Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Prollenium Medical Technologies Inc
6.2.2 Facial Injectables Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Prollenium Medical Technologies Inc Facial Injectables Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Galderma
6.3.2 Facial Injectables Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Galderma Facial Injectables Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Merz Aesthetics
6.4.2 Facial Injectables Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Merz Aesthetics Facial Injectables Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Ipsen Group
6.5.2 Facial Injectables Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Ipsen Group Facial Injectables Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Bloomage BioTechnology
6.6.2 Facial Injectables Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Bloomage BioTechnology Facial Injectables Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Hangzhou Techderm Biological Products
6.7.2 Facial Injectables Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Hangzhou Techderm Biological Products Facial Injectables Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Laboratory Obvieline
6.8.2 Facial Injectables Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Laboratory Obvieline Facial Injectables Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Medytox
6.9.2 Facial Injectables Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Medytox Facial Injectables Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Polymekon
6.10.2 Facial Injectables Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Polymekon Facial Injectables Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Qufu Guanglong Biochem
6.12 Revitacare
6.13 Suneva Medical
6.14 SciVision Biotech
6.15 Speciality European Pharma
6.16 Syneron
6.17 Visionmed
6.18 AQTIS Medical
7 Facial Injectables Manufacturing Cost Analysis
7.1 Facial Injectables Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Facial Injectables
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Facial Injectables Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Facial Injectables Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Facial Injectables Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Facial Injectables Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Facial Injectables Sales Volume Forecast by Type (2017-2022)
11.3 United States Facial Injectables Sales Volume Forecast by Application (2017-2022)
11.4 United States Facial Injectables Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Facial Injectables
Figure United States Facial Injectables Market Size (K Doses) by Type (2012-2022)
Figure United States Facial Injectables Sales Volume Market Share by Type (Product Category) in 2016
Figure Botulinum Toxin Product Picture
Figure Hyaluronic Acid Product Picture
Figure Collagen Product Picture
Figure Particle & Polymer Fillers (PPF) Product Picture
Figure United States Facial Injectables Market Size (K Doses) by Application (2012-2022)
Figure United States Sales Market Share of Facial Injectables by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Ambulatory Surgical Centers Examples
Table Key Downstream Customer in Ambulatory Surgical Centers
Figure Cosmetic Centers Examples
Table Key Downstream Customer in Cosmetic Centers
Figure Dermatology Clinics Examples
Table Key Downstream Customer in Dermatology Clinics
Figure Physician Clinics Examples
Table Key Downstream Customer in Physician Clinics
Figure United States Facial Injectables Market Size (Million USD) by Region (2012-2022)
Figure The West Facial Injectables Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Facial Injectables Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Facial Injectables Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Facial Injectables Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Facial Injectables Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Facial Injectables Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Facial Injectables Sales (K Doses) and Growth Rate (2012-2022)
Figure United States Facial Injectables Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Facial Injectables Market Major Players Product Sales Volume (K Doses) (2012-2017)
Table United States Facial Injectables Sales (K Doses) of Key Players/Suppliers (2012-2017)
Table United States Facial Injectables Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Facial Injectables Sales Share by Players/Suppliers
Figure 2017 United States Facial Injectables Sales Share by Players/Suppliers
Figure United States Facial Injectables Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Facial Injectables Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Facial Injectables Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Facial Injectables Revenue Share by Players/Suppliers
Figure 2017 United States Facial Injectables Revenue Share by Players/Suppliers
Table United States Market Facial Injectables Average Price (USD/Dose) of Key Players/Suppliers (2012-2017)
Figure United States Market Facial Injectables Average Price (USD/Dose) of Key Players/Suppliers in 2016
Figure United States Facial Injectables Market Share of Top 3 Players/Suppliers
Figure United States Facial Injectables Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Facial Injectables Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Facial Injectables Product Category
Table United States Facial Injectables Sales (K Doses) by Region (2012-2017)
Table United States Facial Injectables Sales Share by Region (2012-2017)
Figure United States Facial Injectables Sales Share by Region (2012-2017)
Figure United States Facial Injectables Sales Market Share by Region in 2016
Table United States Facial Injectables Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Facial Injectables Revenue Share by Region (2012-2017)
Figure United States Facial Injectables Revenue Market Share by Region (2012-2017)
Figure United States Facial Injectables Revenue Market Share by Region in 2016
Table United States Facial Injectables Price (USD/Dose) by Region (2012-2017)
Table United States Facial Injectables Sales (K Doses) by Type (2012-2017)
Table United States Facial Injectables Sales Share by Type (2012-2017)
Figure United States Facial Injectables Sales Share by Type (2012-2017)
Figure United States Facial Injectables Sales Market Share by Type in 2016
Table United States Facial Injectables Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Facial Injectables Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Facial Injectables by Type (2012-2017)
Figure Revenue Market Share of Facial Injectables by Type in 2016
Table United States Facial Injectables Price (USD/Dose) by Types (2012-2017)
Figure United States Facial Injectables Sales Growth Rate by Type (2012-2017)
Table United States Facial Injectables Sales (K Doses) by Application (2012-2017)
Table United States Facial Injectables Sales Market Share by Application (2012-2017)
Figure United States Facial Injectables Sales Market Share by Application (2012-2017)
Figure United States Facial Injectables Sales Market Share by Application in 2016
Table United States Facial Injectables Sales Growth Rate by Application (2012-2017)
Figure United States Facial Injectables Sales Growth Rate by Application (2012-2017)
Table Allergan Basic Information List
Table Allergan Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Allergan Facial Injectables Sales Growth Rate (2012-2017)
Figure Allergan Facial Injectables Sales Market Share in United States (2012-2017)
Figure Allergan Facial Injectables Revenue Market Share in United States (2012-2017)
Table Prollenium Medical Technologies Inc Basic Information List
Table Prollenium Medical Technologies Inc Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Prollenium Medical Technologies Inc Facial Injectables Sales Growth Rate (2012-2017)
Figure Prollenium Medical Technologies Inc Facial Injectables Sales Market Share in United States (2012-2017)
Figure Prollenium Medical Technologies Inc Facial Injectables Revenue Market Share in United States (2012-2017)
Table Galderma Basic Information List
Table Galderma Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Galderma Facial Injectables Sales Growth Rate (2012-2017)
Figure Galderma Facial Injectables Sales Market Share in United States (2012-2017)
Figure Galderma Facial Injectables Revenue Market Share in United States (2012-2017)
Table Merz Aesthetics Basic Information List
Table Merz Aesthetics Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Merz Aesthetics Facial Injectables Sales Growth Rate (2012-2017)
Figure Merz Aesthetics Facial Injectables Sales Market Share in United States (2012-2017)
Figure Merz Aesthetics Facial Injectables Revenue Market Share in United States (2012-2017)
Table Ipsen Group Basic Information List
Table Ipsen Group Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Ipsen Group Facial Injectables Sales Growth Rate (2012-2017)
Figure Ipsen Group Facial Injectables Sales Market Share in United States (2012-2017)
Figure Ipsen Group Facial Injectables Revenue Market Share in United States (2012-2017)
Table Bloomage BioTechnology Basic Information List
Table Bloomage BioTechnology Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Bloomage BioTechnology Facial Injectables Sales Growth Rate (2012-2017)
Figure Bloomage BioTechnology Facial Injectables Sales Market Share in United States (2012-2017)
Figure Bloomage BioTechnology Facial Injectables Revenue Market Share in United States (2012-2017)
Table Hangzhou Techderm Biological Products Basic Information List
Table Hangzhou Techderm Biological Products Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Hangzhou Techderm Biological Products Facial Injectables Sales Growth Rate (2012-2017)
Figure Hangzhou Techderm Biological Products Facial Injectables Sales Market Share in United States (2012-2017)
Figure Hangzhou Techderm Biological Products Facial Injectables Revenue Market Share in United States (2012-2017)
Table Laboratory Obvieline Basic Information List
Table Laboratory Obvieline Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Laboratory Obvieline Facial Injectables Sales Growth Rate (2012-2017)
Figure Laboratory Obvieline Facial Injectables Sales Market Share in United States (2012-2017)
Figure Laboratory Obvieline Facial Injectables Revenue Market Share in United States (2012-2017)
Table Medytox Basic Information List
Table Medytox Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Medytox Facial Injectables Sales Growth Rate (2012-2017)
Figure Medytox Facial Injectables Sales Market Share in United States (2012-2017)
Figure Medytox Facial Injectables Revenue Market Share in United States (2012-2017)
Table Polymekon Basic Information List
Table Polymekon Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Polymekon Facial Injectables Sales Growth Rate (2012-2017)
Figure Polymekon Facial Injectables Sales Market Share in United States (2012-2017)
Figure Polymekon Facial Injectables Revenue Market Share in United States (2012-2017)
Table Qufu Guanglong Biochem Basic Information List
Table Revitacare Basic Information List
Table Suneva Medical Basic Information List
Table SciVision Biotech Basic Information List
Table Speciality European Pharma Basic Information List
Table Syneron Basic Information List
Table Visionmed Basic Information List
Table AQTIS Medical Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Facial Injectables
Figure Manufacturing Process Analysis of Facial Injectables
Figure Facial Injectables Industrial Chain Analysis
Table Raw Materials Sources of Facial Injectables Major Players/Suppliers in 2016
Table Major Buyers of Facial Injectables
Table Distributors/Traders List
Figure United States Facial Injectables Sales Volume (K Doses) and Growth Rate Forecast (2017-2022)
Figure United States Facial Injectables Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Facial Injectables Price (USD/Dose) Trend Forecast (2017-2022)
Table United States Facial Injectables Sales Volume (K Doses) Forecast by Type (2017-2022)
Figure United States Facial Injectables Sales Volume (K Doses) Forecast by Type (2017-2022)
Figure United States Facial Injectables Sales Volume (K Doses) Forecast by Type in 2022
Table United States Facial Injectables Sales Volume (K Doses) Forecast by Application (2017-2022)
Figure United States Facial Injectables Sales Volume (K Doses) Forecast by Application (2017-2022)
Figure United States Facial Injectables Sales Volume (K Doses) Forecast by Application in 2022
Table United States Facial Injectables Sales Volume (K Doses) Forecast by Region (2017-2022)
Table United States Facial Injectables Sales Volume Share Forecast by Region (2017-2022)
Figure United States Facial Injectables Sales Volume Share Forecast by Region (2017-2022)
Figure United States Facial Injectables Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Facial Injectables Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 126
    Injectables are a combination of dermal fillers and Botox used in facial aesthetic treatments, which help reduce wrinkles and play a crucial role in rejuvenating facial skin for smoother and younger look. These are injected under the skin or lips to plump up the tissues and gently lift it to restore collagen lost due to aging. Collagen and HA provide essential support to skin and help it retain its elasticity. The glabellar lines, wrinkles, and lines can be reduced with facial aesthetic treatmen......
  • Anti Dermatomycosis Skin Drugs Markets in China
    Published: 17-Jan-2019        Price: US 4000 Onwards        Pages: 221
    China's demand for Anti Dermatomycosis Skin Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry ca......
  • Anti Dermatomycosis Skin Drugs Companies in China
    Published: 17-Jan-2019        Price: US 1800 Onwards        Pages: 71
    This study focuses on China's Anti Dermatomycosis Skin Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the c......
  • Anti Dermatomycosis Skin Drugs Industry Forecasts - China Focus
    Published: 17-Jan-2019        Price: US 1800 Onwards        Pages: 100
    This study focuses on China's Anti Dermatomycosis Skin Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods an......
  • Global Dermatological Drugs Market Insights, Forecast to 2025
    Published: 17-Jan-2019        Price: US 3900 Onwards        Pages: 113
    Dermatology is a field of medicine that is engaged in the diagnosis, prevention, and treatment of various skin, nails, hair diseases, pigmentation, acne, wrinkles, psoriasis, and others. Different techniques are used in dermatology such as topical & systemic medications, laser therapy, radio therapy, photodynamic therapy, vitiligo surgery, dermatological surgery, and others. The global Dermatological Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by ......
  • Global Acne Medication Market Insights, Forecast to 2025
    Published: 17-Jan-2019        Price: US 3900 Onwards        Pages: 111
    Acne medications are drugs that are indicated for the treatment of acne. The global Acne Medication market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Acne Medication market based on company, product type, end user and key regions. This report studies the global market size of Acne Medication in key regions li......
  • Rosacea - Epidemiology Forecast to 2028
    Published: 15-Jan-2019        Price: US 3250 Onwards        Pages: 50
    DelveInsight's "Rosacea - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Rosacea epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028. Markets Covered - United States - EU5 (Germany, France, Italy, Spain, and the United Kingdom) - Japan Study Period: 2016-2028 Rosacea Epidemiology The epidemiology section covers the historical, current......
  • Athlete's Foot (Tinea Pedis) - Pipeline Insight, 2019
    Published: 15-Jan-2019        Price: US 1250 Onwards        Pages: 50
    "Athlete's Foot (Tinea Pedis) - Pipeline Insight, 2019" report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Athlete's Foot (Tinea Pedis) development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. ......
  • Zelboraf - Drug Insights, 2019
    Published: 15-Jan-2019        Price: US 1000 Onwards        Pages: 35
    Introduction DelveInsight's pharmaceuticals report, "Zelboraf Drug Insight, 2019" highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the Zelboraf covering the historical global sales and also provides the Zelboraf sales estimation during the forecasted period (2019-2021). The report also covers the patents information and market exclusivity data, route of synthesis, marke......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs